CRISTHI WILSON-BROWN: Open Payments
NPI 1073988374 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 19 payments from 7 companies in 2025. Trend: 2023 $274 · 2024 $619 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $397 |
| Braeburn Inc. | 5 | $302 |
| Otsuka America Pharmaceutical, Inc. | 3 | $285 |
| E.R. Squibb & Sons, L.L.C. | 2 | $243 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| Alkermes, Inc. | 1 | $114 |
| ABBVIE INC. | 1 | $15 |
Products named: BRIXADI, AUSTEDO XR, ABILIFY MAINTENA, COBENFY, FANAPT, LYBALVI, UZEDY, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
